Our products are for experimental study only
Dimoxamine (CAS: 52842-59-8) is a synthetic compound that belongs to the class of dopamine agonists. The drug has been studied for its potential use in treating Parkinson's disease, but it has not been approved for medical use by any regulatory agency. Dimoxamine is primarily used as a research chemical or experimental drug.
Chemical name
The chemical name for dimoxamine is N-(3,4-dihydroxyphenethyl)-2-aminoethane sulfonic acid.
Molecular formula
The molecular formula for dimoxamine is C10H16N2O5S.
Formula weight
The formula weight for dimoxamine is 284.32 g/mol.
CAS No.
The CAS number for dimoxamine is 52842-59-8.
Top Ten Keywords from Google and Synonyms
Health Benefits of This Product
Dimoxamine has no known health benefits and is not approved for medical use by any regulatory agency. The drug is primarily used as a research chemical or experimental drug.
Potential Effects
The effects of dimoxamine on humans are not well understood, as the drug has not been extensively studied in clinical trials. In animal studies, dimoxamine has been shown to increase dopamine levels in the brain, similar to other dopamine agonist drugs. The drug may have potential in treating movement disorders such as Parkinson's disease, but further research is needed to determine its safety and efficacy.
Product Mechanism
Dimoxamine works by binding to and activating dopamine receptors in the brain. The drug mimics the effects of dopamine, a neurotransmitter responsible for regulating movement, mood, and reward. By increasing dopamine activity, dimoxamine may improve motor function and reduce symptoms of Parkinson's disease.
Safety
As dimoxamine has not been approved for medical use by any regulatory agency, there is limited information on its safety profile. The drug's potential side effects and long-term effects on the brain are not well understood, and its use carries a high risk of adverse effects.
Side Effects
Common side effects of dopamine agonist drugs include nausea, vomiting, dizziness, headache, and fatigue. In some cases, dopamine agonists can cause impulse control disorders such as compulsive gambling, shopping, or eating. Long-term use of dopamine agonists has been associated with an increased risk of developing behavioral addictions and psychosis.
Dosing Information
Due to the lack of regulation and standardization, dosing information for dimoxamine is highly variable and often inaccurate. Users should exercise caution when using this drug and follow the dosage instructions provided by their healthcare provider or researcher. There is currently no established dosage range for dimoxamine in humans.
Conclusion
Dimoxamine is a synthetic compound that belongs to the class of dopamine agonist drugs. The drug has been studied for its potential use in treating Parkinson's disease, but it has not been approved for medical use by any regulatory agency. The drug's safety and efficacy in humans are not well understood, and its use as a research chemical or experimental drug carries a high risk of adverse effects. Therefore, it is essential to exercise caution when using this drug and seek professional help if experiencing adverse effects or symptoms of overdose. Further research is needed to determine the safety and efficacy of dimoxamine in humans
